Product logins

Find logins to all Clarivate products below.


Varicose Vein Treatment Devices – Market Insights – Europe (Supplemental)

Although the COVID-19 global pandemic has negatively impacted the European varicose vein treatment device market in the short term, the market has largely recovered and will grow moderately over the remainder of the forecast period, supported by a shift toward and a changing reimbursement landscape for endovenous ablation technologies, namely ERFA and ELA, which will compete with surgical stripping procedures.

This Medtech 360 Report provides high-level market metrics for varicose vein treatment device market in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2031.

Table of contents


Related Medtech Insights Reports

Report
Dialysis Access Treatment Devices – Market Insights – United States
The US dialysis access treatment device market will grow at a moderate rate due to the increasing adoption of innovative products, positive clinical data, and rising ASPs of specific devices like…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow strongly through the forecast period, driven by various factors such as rising procedure volumes, product launches, and increasing…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…